High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Al-Joharah AlhuqailAreej AlzahraniHannah AlmubarakSarah Al-QadheebLamyaa AlghofailiNisreen AlmoghrabiHamed AlhussainiBen Ho ParkDilek ColakBedri KarakasPublished in: Breast cancer research and treatment (2018)
The overall frequencies of the BRCA germline mutations were 10.2% in breast and 30.7% in ovarian cancer patients. These data shed new light into the prevalence of BRCA mutations in the Arab women population.